drugset / Trial / NCT02434744
Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the safety, tolerability and efficacy of the combination of KD026 and metformin compared to placebo and metformin on improving glycemic control in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLx-4090 | Small molecule | 100 mg | — |
| Subject | SLx-4090 | Small molecule | 150 mg | — |
| Subject | SLx-4090 | Small molecule | 200 mg | — |
| Background | Metformin | Small molecule | — | — |